Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Assist Reprod Genet ; 21(3): 89-90, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15202737

RESUMO

PURPOSE: To determine if hypergonadotropic hypogonadism related to galactosemia could be linked to anomaly of the circulating FSH. A 26-year-old woman, suffering GALT (Galactoso-1-phosphate uridyltransferase) had a premature ovarian failure with amenorrhea since the age of 19. The circulating level for FSH was 83 and 34 mU/mL for LH. METHODS: After treatment with a hormonal substitution cycle including estradiol and progesterone, the patient underwent stimulations with recombinant FSH. The first cycle, one 16-mm diameter follicle and the second cycle one follicle of 17.5 mm of diameter were obtained at the time of ovulation induction. RESULTS: The patient conceived and delivered a female baby weighting 3.38 kg after the second stimulation protocol. CONCLUSIONS: The impact of galactosemia on the ovary seems rather related to the absence of recognition of circulating FSH by its receptor and not to a toxic alteration of the ovary by itself as it is currently reported. The rFSH treatment following hormonal substitution cycles allows to overcome infertility problems.


Assuntos
Hormônio Foliculoestimulante/uso terapêutico , Galactosemias/complicações , Hipogonadismo/complicações , Infertilidade Feminina/tratamento farmacológico , Adulto , Parto Obstétrico , Estradiol/uso terapêutico , Feminino , Hormônio Foliculoestimulante/sangue , Galactosemias/enzimologia , Humanos , Infertilidade Feminina/etiologia , Indução da Ovulação , Gravidez , Resultado da Gravidez , Progesterona/uso terapêutico , Proteínas Recombinantes/uso terapêutico , UTP-Hexose-1-Fosfato Uridililtransferase/deficiência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA